News

Variability in platelet size may be biomarker for Parkinson’s: Study

Researchers have discovered a new genetic link between platelets in the bloodstream and Parkinson’s disease, according to a large-scale genetic study that investigated associations between blood measures and neurological and psychiatric diseases. Variation in platelet size, called platelet distribution width (PDW), was found to be broader in Parkinson’s patients…

DBS can ease familial and idiopathic Parkinson’s symptoms equally

Subthalamic deep brain stimulation (DBS) may bring benefits to people with Parkinson’s regardless of whether the disease is caused by a gene mutation or appears in patients with no associated mutations, a study in Spain found. Researchers investigated this surgical treatment’s use in people with LRRK2 and PRKN mutations — …

Study Examines How Caregiver Strain Affects Patients

People with Parkinson’s disease are more likely to report a good quality of life if their caregivers are not strained, a new study suggests. “As caregiver strain was found to be related to patients’ QoL [quality of life], improvement in QoL for PD [Parkinson’s disease] patients may hinge on…

Rehab Center Will Test Outpatient Monitoring System

Shirley Ryan AbilityLab, a rehabilitation center located in Chicago, Illinois, will conduct a study that will use Datos Health‘s remote care platform Open Care to monitor physical activity in people with Parkinson’s disease and other neurological disorders. “The research study will allow us to determine the feasibility…

How Parkinson’s May Affect Sexes Differently Examined in US Study

Men with mild-to-moderate Parkinson’s disease may experience greater effects of the disease on certain aspects of their life than women, according to a study of patients living in the southeastern U.S. Specifically, men were found to have worse motor symptoms, daily life-related impairments, disease-related quality of life, and more…

Video-based AI System Approved in China for Use in Parkinson’s

Nervtex’s MoDAS artificial intelligence (AI) system has become the first video-based, AI-powered medical device to win regulatory approval for assessing motor symptoms in Parkinson’s disease and other movement disorders, according to a company press release. The AI system, which analyzes motor symptoms based on video recorded on a…

ATH434 Preserves Sense of Smell, Aids Neurons in Mouse Model

ATH434, Alterity Therapeutics’ experimental oral therapy, prevented a loss in the sense of smell — an early and common symptom of Parkinson’s disease — in a mouse model, and helped to preserve nerve cells and restore motor skills in older animals, a study showed. These findings add to those…